Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically III children.

K Nichols, CEK Chung EunKyoung, CA Knoderer… - 2016 - cabidigitallibrary.org
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.

K Nichols, EK Chung, CA Knoderer… - Antimicrobial Agents …, 2015 - europepmc.org
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial …, 2015 - pubmed.ncbi.nlm.nih.gov
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial …, 2016 - khu.elsevierpure.com
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

[PDF][PDF] Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

K Nichols, EK Chung, CA Knoderer, LE Buenger… - 2015 - zeltronpharma.com
MATERIALS AND METHODS Patient population. Patients 9 months to 11 years of age who
were admitted to a pediatric intensive care unit were eligible for the study if they were …

[PDF][PDF] Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

K Nichols, EK Chung, CA Knoderer, LE Buenger… - 2015 - zeltronpharma.com
MATERIALS AND METHODS Patient population. Patients 9 months to 11 years of age who
were admitted to a pediatric intensive care unit were eligible for the study if they were …

[PDF][PDF] Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

CA Knoderer, KR Nichols, EK Chung, LE Buenger… - core.ac.uk
MATERIALS AND METHODS Patient population. Patients 9 months to 11 years of age who
were admitted to a pediatric intensive care unit were eligible for the study if they were …

Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

CA Knoderer, KR Nichols… - Antimicrobial …, 2016 - digitalcommons.butler.edu
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillintazobactam in children hospitalized in …

[HTML][HTML] Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial Agents …, 2016 - ncbi.nlm.nih.gov
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …